These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 30605829)
1. Optimization of novel benzofuro[3,2-b]pyridin-2(1H)-one derivatives as dual inhibitors of BTK and PI3Kδ. Liu L; Li X; Cheng Y; Wang L; Yang H; Li J; He S; Shuangjie Wu ; Yin Q; Xiang H Eur J Med Chem; 2019 Feb; 164():304-316. PubMed ID: 30605829 [TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of benzofuro[3,2-b]pyridin-2(1H)-one derivatives as anti-leukemia agents by inhibiting Btk and PI3Kδ. Liu L; Shi B; Li X; Wang X; Lu X; Cai X; Huang A; Luo G; You Q; Xiang H Bioorg Med Chem; 2018 Aug; 26(15):4537-4543. PubMed ID: 30077608 [TBL] [Abstract][Full Text] [Related]
3. Discovery and structure-activity relationship of novel diphenylthiazole derivatives as BTK inhibitor with potent activity against B cell lymphoma cell lines. Guo X; Yang D; Fan Z; Zhang N; Zhao B; Huang C; Wang F; Ma R; Meng M; Deng Y Eur J Med Chem; 2019 Sep; 178():767-781. PubMed ID: 31234030 [TBL] [Abstract][Full Text] [Related]
4. Discovery of novel quinazolinone derivatives as high potent and selective PI3Kδ and PI3Kδ/γ inhibitors. Ma CC; Zhang CM; Tang LQ; Liu ZP Eur J Med Chem; 2018 May; 151():9-17. PubMed ID: 29601991 [TBL] [Abstract][Full Text] [Related]
5. Synthesis and Evaluation of Novel 2H-Benzo[e]-[1,2,4]thiadiazine 1,1-Dioxide Derivatives as PI3Kδ Inhibitors. Gong YP; Tang LQ; Liu TS; Liu ZP Molecules; 2019 Nov; 24(23):. PubMed ID: 31775363 [TBL] [Abstract][Full Text] [Related]
6. Discovery of potent and highly selective covalent inhibitors of Bruton's tyrosine kinase bearing triazine scaffold. Teng Y; Lu X; Xiao M; Li Z; Zou Y; Ren S; Cheng Y; Luo G; Xiang H Eur J Med Chem; 2020 Aug; 199():112339. PubMed ID: 32402933 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological evaluation of novel benzothiadiazine derivatives as potent PI3Kδ-selective inhibitors for treating B-cell-mediated malignancies. Ma X; Wei J; Wang C; Gu D; Hu Y; Sheng R Eur J Med Chem; 2019 May; 170():112-125. PubMed ID: 30878826 [TBL] [Abstract][Full Text] [Related]
8. Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor. Liang X; Li F; Chen C; Jiang Z; Wang A; Liu X; Ge J; Hu Z; Yu K; Wang W; Zou F; Liu Q; Wang B; Wang L; Zhang S; Wang Y; Liu Q; Liu J Eur J Med Chem; 2018 Aug; 156():831-846. PubMed ID: 30053721 [TBL] [Abstract][Full Text] [Related]
9. Discovery and Biological evaluation of pyrimido[4,5-d]pyrimidine-2,4(1H,3H)-dione derivatives as potent Bruton's tyrosine kinase inhibitors. Diao Y; Fang X; Song P; Lai M; Tong L; Hao Y; Dou D; Liu Y; Ding J; Zhao Z; Xie H; Li H Bioorg Med Chem; 2019 Aug; 27(15):3390-3395. PubMed ID: 31221612 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of novel 1-substituted 3-(3-phenoxyprop-1-yn-1-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amines as potent Bruton's tyrosine kinase (BTK) inhibitors. Zheng N; Hao Q; Lin K; Pan J; Li Y; Zhou W Bioorg Med Chem Lett; 2019 Jan; 29(2):225-229. PubMed ID: 30522954 [TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel 1-substituted 3-(6-phenoxypyridin-3-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine analogs as selective BTK inhibitors for the treatment of mantle cell lymphoma. Ran F; Liu Y; Yu S; Guo K; Tang W; Chen X; Zhao G Bioorg Chem; 2020 Jan; 94():103367. PubMed ID: 31685258 [TBL] [Abstract][Full Text] [Related]
12. Novel 6-aryl substituted 4-pyrrolidineaminoquinazoline derivatives as potent phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. Xin M; Duan W; Feng Y; Hei YY; Zhang H; Shen Y; Zhao HY; Mao S; Zhang SQ Bioorg Med Chem; 2018 May; 26(8):2028-2040. PubMed ID: 29534936 [TBL] [Abstract][Full Text] [Related]
13. Single and combined BTK and PI3Kδ inhibition with acalabrutinib and ACP-319 in pre-clinical models of aggressive lymphomas. Spriano F; Tarantelli C; Gaudio E; Gerlach MM; Priebe V; Cascione L; Bernasconi E; Targa A; Mascia M; Dirnhofer S; Stathis A; Zucca E; Bertoni F Br J Haematol; 2019 Dec; 187(5):595-601. PubMed ID: 31355927 [TBL] [Abstract][Full Text] [Related]
14. Discovery of pyrido[3,4-b]indol-1-one derivatives as novel non-covalent Bruton's tyrosine kinase (BTK) inhibitors. Dou D; Sha W; Diao Y; Su R; Qiao Y; Yu Z; Zhao Z; Li H; Chen Z; Xu Y Bioorg Chem; 2022 Feb; 119():105541. PubMed ID: 34910982 [TBL] [Abstract][Full Text] [Related]
15. SAR study of 5-alkynyl substituted quinazolin-4(3H)-ones as phosphoinositide 3-kinase delta (PI3Kδ) inhibitors. Wei M; Zhang X; Wang X; Song Z; Ding J; Meng LH; Zhang A Eur J Med Chem; 2017 Jan; 125():1156-1171. PubMed ID: 27846451 [TBL] [Abstract][Full Text] [Related]
16. New 2,6,9-trisubstituted purine derivatives as Bcr-Abl and Btk inhibitors and as promising agents against leukemia. Bertrand J; Dostálová H; Krystof V; Jorda R; Castro A; Mella J; Espinosa-Bustos C; María Zarate A; Salas CO Bioorg Chem; 2020 Jan; 94():103361. PubMed ID: 31699386 [TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and biological evaluation of novel dithiocarbamate-substituted diphenylaminopyrimidine derivatives as BTK inhibitors. Zhai Z; Li R; Bai X; Ning X; Lin Z; Zhao X; Jin Y; Yin Y Bioorg Med Chem; 2019 Sep; 27(18):4124-4142. PubMed ID: 31395509 [TBL] [Abstract][Full Text] [Related]
18. Discovery of pyrazolopyrimidine derivatives as potent BTK inhibitors with effective anticancer activity in MCL. Ran F; Liu Y; Liu M; Zhang D; Wang P; Dong J; Tang W; Zhao G Bioorg Chem; 2019 Aug; 89():102943. PubMed ID: 31031018 [TBL] [Abstract][Full Text] [Related]
19. Novel amino acid-substituted diphenylpyrimidine derivatives as potent BTK inhibitors against B cell lymphoma cell lines. Wang C; Li S; Meng Q; Sun X; Li H; Shu X; Sun H; Liu K; Liu Z; Ma X Bioorg Med Chem; 2018 Aug; 26(14):4179-4186. PubMed ID: 30006143 [TBL] [Abstract][Full Text] [Related]
20. Discovery of novel quinazoline derivatives as potent PI3Kδ inhibitors with high selectivity. Teng Y; Li X; Ren S; Cheng Y; Xi K; Shen H; Ma W; Luo G; Xiang H Eur J Med Chem; 2020 Dec; 208():112865. PubMed ID: 32987316 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]